Prior studies have demonstrated the prognostic and functional significance of MARK3 in various cancers, including breast, ovarian, colorectal, and cervical cancers [12,13,14], but its role in endometrial cancer has remained unexplored until now. This evidence concerns the gene MARK3 and cervical cancer.